Education Qualifications: MBBS, FRCS (Edin & Glasg), M Med (Surg), FAMS (Urology)
Prof Christopher Cheng graduated from Singapore University in 1982 and obtained his post-graduate degree in Surgery FRCS in 1986, and FAMS (Urology) from the Academy of Medicine, Singapore in 1993. He obtained his Uro-oncology Fellowship after spending two years at the Mayo Clinic, USA from 1990 to 1992. Prof Cheng’s clinical and research fields of interest include uro-oncology, renal transplantation (living-related and cadaveric) and minimally invasive surgery.
He is a member of the Transplant Advisory Committee at the Ministry of Health, Singapore. He is also the Chairman of the Robotic Minimally Invasive Surgery Steering Committee at SGH. Prof Cheng also spearheaded the project ‘A Minimally-Invasive Surgery (MIS) research centre based on a robotic surgery unit da Vinci system) and an image-guided intervention unit’ funded from Ministry of Health, Singapore in 2003. Prof Cheng was the Principal Investigator to develop the Urological Oncology Unit at the Department of Urology for Basic and Clinical Research in Urinary Tract Cancer, fully funded by the then Singapore Totalisator Board.
He has over 90 publications in local and international journals on Prostate Cancers, Bladder Cancers and Stone Diseases. He has contributed to several book chapters on urology in local and international publications. He is on the editorial board of several well-known journals, namely Journal of Robotic Surgery and Oncology & Haematology News. He was the Editor of the MOH Clinical Practice Guidelines on Prostate Cancer, published by the Ministry of Health in May 2000.
He was one of the workgroup members of the Clinical Practice Guidelines on Health Screening published by Ministry of Health, Singapore in June 2003.
Professional Appointments and Committee Memberships:
• Senior Advisor, SingHealth Board of Advisors
• Member of Transplant Advisory Committee, Ministry of Health Singapore
• Chairman, Robotic Minimally Invasive Surgery Steering Committee, SGH
• Principal Investigator, Urological Unit, Department of Urology for Basic and Clinical Research in Urinary Tract Cancer
Christopher W S Cheng, Roger E Cupps, John D Earle, George M Farrow, Michael M Lieber. Nuclear deoxyribonucleic acid content measured by static cytometry: important prognostic association for patients with clinically localised prostate carcinoma treated by external beam radiotherapy. J of Urol 1992; 147: 794 - 797
Christopher W S Cheng, Mark Frydenberg, Erik Bergstralh and Horse Zincke. Radical Prostatectomy for Pathological Stage C (PC) Prostate Cancer: Influence of Pathologic Variables and Adjuvant Treatment on Disease Outcome. J of Urol 1992; 147,
Christopher W S Cheng, Horst Zincke. Stage D1 Prostate Cancer: A Non-randomized comparison of Conservative Treatment Options versus Radical Prostatectomy. Cancer 1993; 71(3): 996
Christopher Cheng, Mark Frydenberg, Erik Bergstralh and Horse Zincke . Radical Prostatectomy for Pathological Stage C (PC) Prostate Cancer. Urology September 1993; 42 (3): 283 – 291
Wai S Cheng, Erik J Bergstralh, Mark Fridenberg, Horst Zincke. Prostatic-Specific Antigen Levels after Radical Prostatectomy and Immediate Adjuvant Hormonal Treatment for Stage D1 Prostate Cancer Are Predictive of Early Disease Outcome. European Urology 1994; 25:189-193